1-154429203-G-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000565.4(IL6R):​c.93G>A​(p.Ala31Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.15 in 1,610,256 control chromosomes in the GnomAD database, including 18,943 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1439 hom., cov: 31)
Exomes 𝑓: 0.15 ( 17504 hom. )

Consequence

IL6R
NM_000565.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.21

Publications

35 publications found
Variant links:
Genes affected
IL6R (HGNC:6019): (interleukin 6 receptor) This gene encodes a subunit of the interleukin 6 (IL6) receptor complex. Interleukin 6 is a potent pleiotropic cytokine that regulates cell growth and differentiation and plays an important role in the immune response. The IL6 receptor is a protein complex consisting of this protein and interleukin 6 signal transducer (IL6ST/GP130/IL6-beta), a receptor subunit also shared by many other cytokines. Dysregulated production of IL6 and this receptor are implicated in the pathogenesis of many diseases, such as multiple myeloma, autoimmune diseases and prostate cancer. Alternatively spliced transcript variants encoding distinct isoforms have been identified in this gene. A pseudogene of this gene is found on chromosome 9. [provided by RefSeq, Aug 2020]
IL6R Gene-Disease associations (from GenCC):
  • hyper-IgE recurrent infection syndrome 5, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 1-154429203-G-A is Benign according to our data. Variant chr1-154429203-G-A is described in ClinVar as [Benign]. Clinvar id is 1164401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.2 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL6RNM_000565.4 linkc.93G>A p.Ala31Ala synonymous_variant Exon 2 of 10 ENST00000368485.8 NP_000556.1 P08887-1A0N0L5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL6RENST00000368485.8 linkc.93G>A p.Ala31Ala synonymous_variant Exon 2 of 10 1 NM_000565.4 ENSP00000357470.3 P08887-1

Frequencies

GnomAD3 genomes
AF:
0.128
AC:
19471
AN:
151990
Hom.:
1436
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0623
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.108
Gnomad ASJ
AF:
0.193
Gnomad EAS
AF:
0.107
Gnomad SAS
AF:
0.161
Gnomad FIN
AF:
0.159
Gnomad MID
AF:
0.140
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.129
GnomAD2 exomes
AF:
0.139
AC:
34830
AN:
250842
AF XY:
0.141
show subpopulations
Gnomad AFR exome
AF:
0.0603
Gnomad AMR exome
AF:
0.0767
Gnomad ASJ exome
AF:
0.171
Gnomad EAS exome
AF:
0.113
Gnomad FIN exome
AF:
0.163
Gnomad NFE exome
AF:
0.163
Gnomad OTH exome
AF:
0.150
GnomAD4 exome
AF:
0.152
AC:
222252
AN:
1458148
Hom.:
17504
Cov.:
33
AF XY:
0.152
AC XY:
110365
AN XY:
724486
show subpopulations
African (AFR)
AF:
0.0549
AC:
1834
AN:
33412
American (AMR)
AF:
0.0799
AC:
3566
AN:
44656
Ashkenazi Jewish (ASJ)
AF:
0.175
AC:
4563
AN:
26098
East Asian (EAS)
AF:
0.110
AC:
4338
AN:
39552
South Asian (SAS)
AF:
0.144
AC:
12421
AN:
86188
European-Finnish (FIN)
AF:
0.165
AC:
8790
AN:
53364
Middle Eastern (MID)
AF:
0.166
AC:
955
AN:
5752
European-Non Finnish (NFE)
AF:
0.159
AC:
176745
AN:
1108918
Other (OTH)
AF:
0.150
AC:
9040
AN:
60208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
9923
19846
29770
39693
49616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6208
12416
18624
24832
31040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.128
AC:
19480
AN:
152108
Hom.:
1439
Cov.:
31
AF XY:
0.128
AC XY:
9508
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.0621
AC:
2577
AN:
41506
American (AMR)
AF:
0.107
AC:
1642
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.193
AC:
669
AN:
3470
East Asian (EAS)
AF:
0.107
AC:
554
AN:
5176
South Asian (SAS)
AF:
0.163
AC:
785
AN:
4820
European-Finnish (FIN)
AF:
0.159
AC:
1676
AN:
10568
Middle Eastern (MID)
AF:
0.130
AC:
38
AN:
292
European-Non Finnish (NFE)
AF:
0.163
AC:
11081
AN:
67974
Other (OTH)
AF:
0.132
AC:
277
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
877
1754
2630
3507
4384
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
218
436
654
872
1090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.142
Hom.:
2382
Bravo
AF:
0.120
Asia WGS
AF:
0.157
AC:
545
AN:
3478
EpiCase
AF:
0.164
EpiControl
AF:
0.160

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

IL6R-related disorder Benign:1
Oct 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.6
DANN
Benign
0.41
PhyloP100
-2.2
PromoterAI
-0.024
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228144; hg19: chr1-154401679; COSMIC: COSV59816615; COSMIC: COSV59816615; API